Skip to main content
. 2023 Sep 13;23(4):397–402. doi: 10.1007/s40268-023-00438-2

Fig. 2.

Fig. 2

Hemodynamic and non-hemodynamic effects related to sacubitril/valsartan treatment depicted with their molecular mechanisms. BNP B-type natriuretic peptide, NEP neprilysin, NT-proBNP N-terminal pro-B-type natriuretic peptide, sST2 soluble interleukin 1 receptor-like 1